SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009650
Filing Date
2024-07-02
Accepted
2024-07-02 08:30:13
Documents
15
Period of Report
2024-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20240627x8k.htm   iXBRL 8-K 36957
  Complete submission text file 0001558370-24-009650.txt   192589

Data Files

Seq Description Document Type Size
2 EX-101.SCH chrs-20240627.xsd EX-101.SCH 4526
3 EX-101.DEF chrs-20240627_def.xml EX-101.DEF 3156
4 EX-101.LAB chrs-20240627_lab.xml EX-101.LAB 12262
5 EX-101.PRE chrs-20240627_pre.xml EX-101.PRE 11149
17 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20240627x8k_htm.xml XML 4903
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 241092974
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)